Serving the Growing Multi-Billion Dollar Hemp Renaissance

At Barrel Hemp Co. we are very excited about the future of Hemp. Grow with us as we are making inroads into developing one of the largest Hemp operation in the United States.

About Us

Barrel Hemps’ phase one base of operations is a 600 acre farm within the Farm-to-Fork agricultural powerhouse known as the Sacramento Valley. This area boasts an agri-economy of over $7 Billion and produces some of the nation’s most diverse and high-quality crops year-round.

Why Hemp?

Hemp has a number of highly profitable components and applications; the properties of Hemp fibres make it comparable to cotton and synthetic materials; Hemp is also a high protein superfood and the plant contains highly desirable CBD compounds.

About Hemp

Growing Market

We are anticipating Explosive Growth in this sector and our potential revenue.

Nutrition

Hemp foods begin with hemp seeds, which contain a perfect balance of omega 3 and 6, iron, vitamin E and all of the essential amino acids.

CBD Benefits

The high value CBD content from the Hemp can produced and sold in a number of forms from oils, distillates and isolates.

What is Hemp?

To the untrained eye, hemp and marijuana can appear similar, however, Hemp is naturally high in Cannabidiol (CBD) and low in Tetrahydrocannabinol (THC), the reverse of marijuana. The U.S. Federal Agricultural Act of 2014 (aka the Farm Bill) defined “industrial hemp” and distinguished it legally from marijuana. A ‘0.3 percent THC or less’ qualification for hemp was enshrined in Section 7606 of the Agricultural Act and renewed when Congress approved the 2018 Farm Bill. The Farm any plant that tops 0.3 percent THC is considered marijuana and is currently Federally illegal to grow. THC induces psychoactive effects (gets the user “high”), while CBD does not contain any psychoactive properties. CBD has been steadily gaining notoriety for its effect on seizures, anxiety, migraine pain, anti-inflammation and even body temperature. Due to these studied benefits, as well as the CBD products are cropping up. The Hemp plant comes in a number of varieties and uses for the plant range from industrial to consumer textiles, paper and building materials to food and medicines.

Hemp seeds contain a perfect balance
of omega 3 and 6, iron, vitamin E and
all of the essential amino acids.

Hemp proteins are easier to digest than
animal proteins, and with a harvest cycle
that requires much less carbon concentration than livestock, it’s easier on the environment.

Hemp seeds contain one of the most
nutritionally complete food sources in the world. The seeds may be eaten whole, shelled, raw, toasted, plain or flavoured.

The seeds can also be pressed for oil,
which results in seed cake that can be
ground into flour and protein powder.

Hemp fibers make it comparable
to cotton and synthetic materials.

Super Food

Hemp seeds are classified as a nut, having an outer sheath, a hard shell and an inner kernel. Hemp seeds generally contain 30–35% oil by weight, with some varieties containing up to 50% oil. Hempseeds contain anti-oxidants, protein, carotene, phytosterols and phospholipids as well as several minerals including calcium, magnesium, sulphur, potassium, iron, zinc and phosphorus. They are a source of complete protein and contain all 20 known amino acids, including the nine essential amino acids. Hemp seed oil is rich in nutrients and is typically comprised of approximately 25-35% fatty acids, 20-25% protein, 20-30% carbohydrates, and 10-15% fiber. The oil contains vitamins A, B1, B2, B3, B6, C, D and E (a natural anti-oxidant), all in an easily digestible form. The essential fatty acid (EFA) content, contains Linoleic Acid (LA) and Linolenic Acid (LNA) and is a great source of omega-6 and omega-3 polyunsaturated fatty acids (PUFA). These fatty acids comprise of the most desirable contents of the oil, especially due to the ratios in which they exist. The 3:1 ratio of LA to LNA is alleged to be optimal for nutrition and the additional presence of gamma-linolenic acid (GLA) in hemp seed oil ultimately makes its nutritional value superior to most comparable seed oils.

CBD Revolution

Scientists have identified over 100 different cannabinoids, but the two most well-known and well-researched are THC and CBD. CBD, or cannabidiol, has become increasingly popular within the health & wellness and beauty industry. According to data compiled by Brightfield Group, the U.S. CBD market is expected to reach USD 22 Billion by 2022 CBD is being touted as a treatment for ailments ranging from anxiety to cancer and the world is becoming increasingly aware of CBD and its benefits. CBD products already come in a number of forms such as flower, oils, edibles and tinctures and the U.S. has already approved a CBD-based drug, Epidiolex, to be used to treat epilepsy among children. The demand for CBD continues to grow and new products like beverages and foods are rapidly emerging. CBD is the second most abundant compound in hemp, typically representing up to 40% of its extracts. The production of hemp oil involves extracting the fatty acids from the stalks of the cannabis plant. Within these fatty acids fat-soluble substances can be found, and as cannabinoids are fat-soluble, they come out of the plant, dissolved in the oil.

Linked with the ability to reduce nausea and anxiety and lower levels of depression.

Alternative remedy for diabetes, multiple sclerosis and much more.

Anti-inflammatory &
anti-psychotic properties.

Properties enabling CBD to fight tumors.

High Growth Marketspace

The cannabis component CBD could see a sales boom in the coming years.

Source: Brightfield Group

Management

Harpreet Sangha

Chairman & Director

As Chairman Mr. Sangha will lead Barrel Hemp Co as it focuses on reviewing and acquiring exciting new projects in the hemp sector. Mr. Sangha possesses a unique combination of fund raising and managerial skills, having started his career over 30 years ago as an Investment Advisor and has gained an affinity for raising capital. Mr. Sangha has served in Board positions, Chairman, and CEO for a number of public companies.

Craig Alford

President, CEO & Director

Mr. Alford holds both an Honors Bachelor and Master’s Degree of Science. He has worked in over 30 countries which has included independent consulting assignments and positions within the management of major and junior public companies. Mr. Alford has assisted large public companies, the World Bank and the China-Africa Development Fund in tax policy and investment risk. He has been responsible for budgeting and the expenditure of hundreds of millions of dollars and has developed comprehensive economic analysis for billion dollar M & A transactions. Mr. Alford has played a key role in successfully raising capital while serving as a Director and within executive positions for a number of public companies.

Sonny Janda

BA Independent & Director

Mr. Janda holds a Bachelor of Arts degree, with a major in Economics and has a solid background in finance and real estate. Mr. Janda had exposure to capital markets as a junior analyst on various public and private companies; including mining, exploration, real estate development & acquisition and the agriculture-tech sector. He has been involved with the construction of over half a million sq. feet and implementation of 1,000 acres of walnuts and vineyard predominantly within both Northern California and British Columbia. Mr. Janda’s current projects include high-rise residential, large format retail/commercial centers, apartment complexes, as well as large precious metal exploration projects in Africa and related project financing.

Lowell Holden

CFO & Director

Since 1983, Mr. Holden has owned and operated his own consulting firm, LS Enterprises, Inc., which provides business consulting, accounting and other services to businesses. Mr. Holden has a broad range of business experience including managing, securing financing, structuring of transactions, and is experienced and knowledgeable in managing relationships with customers, financing institutions and stockholders. Presently Mr. Holden serves as the Chief Financial Officer of Skkynet Cloud Systems, Inc (SKKY) and Chief Financial Officer and director of EMR Technology, Chief Executive Officer and director of PTS, Inc (PTSH. Mr. Holden also has a background in assisting companies in fulfilling their financial auditing and SEC reporting requirements. Mr. Lowell Holden has a Bachelor of Science degree from Iowa State University.

Adam Fishman

Managing Director Israel

Adam Fishman is an attorney by profession and practiced law for 10 years in both private practice and as in-house counsel at United Airlines. Until 2005, Adam served as the first Chicago area Director for the American Israel Public Affairs Committee (AIPAC) tripling its reach in the region. Adam's Israel business development and consulting career began after moving to Israel in 2005 where he was the VP of Legal and Director of Corporate Development for SLK Development & Consulting Group Ltd. and serving as the Executive Director of American Friends of Likud. In these capacities, Adam has developed relationships with Israel’s hi-tech business, innovation, security and political leaders including CEOs, Ministers, and Ambassadors, as well as Middle East political and security experts and journalists.

Advisors

Dr. Ravindranath Kancherla

Chairman of Advisory Board

Dr. Ravindranath Kancherla, M.S., FRCS (Glasgow) FRCS (Edin.) is the founder of Global Hospitals Private Limited in 1998 and also serves as its Managing Director. Dr. Kancherla serves as Vice President of Shiridi Sai Medical Trust, Nellore. He worked about 7 years in the United Kingdom in various positions at Darlington Memorial Hospital, Hammersmith Hospital, St. Mark's Hospital and King's College Hospital. He has performed over 15,000 Laparoscopic Operations including over 9000 Laparoscopic Gall Bladder operations. He was Founding member and served as Treasurer of Endoscopic & Laparoscopic Surgeons of Asia, Singapore (First Indian to occupy this post). He served as Hon. Secretary of Indian Association of Gastrointestinal & Endosurgeons from 1998 to 2000. He served as Vice President of Endoscopic & Laparoscopic Surgeons of Asia, Singapore from 2001 to 2003. He served as President of Indian Association of Gastrointestinal Endosurgeons from 2000 to 2002 and President Iages from 2002 to 2004. Dr. Kancherla serves as the Chairman of the Board for Global Hospitals Private Limited. He has been Non-Executive and Independent Director at Laurus Labs Limited since May 18, 2017. He has been Director of Black Cactus Global, Inc. since December 11, 2017. He serves as a Director of Institute of Laparoscopic Training Center, Hyderabad (Recognized by ELSA, Singapore). He serves as Member of St. Mark's Association, London. He is Guest Faculty of Scientific Committee member for many International meetings of Endosurgery, Laparoscopic Surgery & G1 Surgery. Dr. Kancherla received his Master of Science from Madras University in 1984 and was granted his Bachelor of Medicine / Bachelor of Surgery in 1980 from Sri Venkateswara Medical College, in Tirupati, AP, India

Dr. Kancheria is a distinguished and internationally recognized Gastrointestinal Endosurgeon and a Fellow of both the Royal College of Surgeons of Edinburgh and Glasgow. Dr. Kancheria is the founder and Chairman of Global Hospitals Group, India’s first multi-organ transplant center. The doctor’s specialized field has led him to work at numerous hospitals in the U.K. as well as serving as a guest faculty in Germany, Italy, Japan, India, and the U.S. Dr. Kancheria has been the recipient of several Lifetime Achievement awards in India.

In addition to his significant medical achievements, Dr. Kancheria has led an array of philanthropic initiatives, including the construction of a high school in an underserved district, Housing Facilities in under-resourced communities, and a hospital for the poor. Dr. Kancherias’ years of research and practice will be of critical importance to Barrel Hemp as we develop new healthcare CBD applications.

Thank you! Your submission has been received!
Something went wrong, please try again.
1-702-595-2247
8275 S. Eastern Ave. Suite 200, Las Vegas, NV, 89123